Skip to main content
. 2020 Oct 26;10(11):871. doi: 10.3390/diagnostics10110871

Figure 1.

Figure 1

Study design for aspirin (acetylsalicylic acid (ASA)) sensitivity testing. Once patient eligibility was established, each patient underwent light transmission aggregometry (LTA) testing to establish ASA sensitivity. Platelets were considered not inhibited by ASA if there was evidence of ≥20% maximal platelet aggregation after activation with arachidonic acid.